Matches in Wikidata for { <http://www.wikidata.org/entity/Q64109963> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q64109963 description "article scientifique publié en 2015" @default.
- Q64109963 description "artículu científicu espublizáu en setiembre de 2015" @default.
- Q64109963 description "im Dezember 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64109963 description "scientific article published on 15 September 2015" @default.
- Q64109963 description "wetenschappelijk artikel" @default.
- Q64109963 description "наукова стаття, опублікована в грудні 2015" @default.
- Q64109963 name "Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry" @default.
- Q64109963 name "Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry" @default.
- Q64109963 type Item @default.
- Q64109963 label "Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry" @default.
- Q64109963 label "Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry" @default.
- Q64109963 prefLabel "Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry" @default.
- Q64109963 prefLabel "Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry" @default.
- Q64109963 P1433 Q64109963-5FB915BB-4BFF-47F3-971D-915887C71253 @default.
- Q64109963 P1476 Q64109963-FD8339AA-4C29-47B0-A46E-841C2549D2EA @default.
- Q64109963 P2093 Q64109963-015A21E7-24A0-4B94-B1EC-47308F5A2135 @default.
- Q64109963 P2093 Q64109963-1A023225-1BC1-49D1-8B62-6B16A27C3D39 @default.
- Q64109963 P2093 Q64109963-207168D8-0F1B-4821-B38C-A07FDCB9645C @default.
- Q64109963 P2093 Q64109963-7E99BEEF-2768-4CAB-B28D-FCF88A998C5A @default.
- Q64109963 P2093 Q64109963-A15234D7-C9A0-4090-AC59-111525F95B92 @default.
- Q64109963 P2093 Q64109963-BEDD12EE-EB3E-4180-A20E-C28F78A7064B @default.
- Q64109963 P2093 Q64109963-BF9CE202-0238-4EDE-982F-D0BEB8E7CF1F @default.
- Q64109963 P2093 Q64109963-E753BE27-95CB-4E9C-A30A-5F4398259099 @default.
- Q64109963 P2860 Q64109963-37E66BFB-3C31-412F-B7CD-AA63562690EB @default.
- Q64109963 P2860 Q64109963-5F772CFE-11DB-41F3-B7CC-3B0EB48075AF @default.
- Q64109963 P2860 Q64109963-660AE3A4-3ACC-4A8F-AB93-F033C9C9FBC2 @default.
- Q64109963 P2860 Q64109963-98825764-8097-4CD9-B093-5AC97B8CDCB3 @default.
- Q64109963 P2860 Q64109963-AB1440D4-4F02-4551-9A43-FE03C427CCC6 @default.
- Q64109963 P2860 Q64109963-F8A5F4A0-581A-4AD7-B9C8-3A1560BD6EC0 @default.
- Q64109963 P2860 Q64109963-FB23470C-0CD3-4EFD-A0DF-060205A5D299 @default.
- Q64109963 P2860 Q64109963-FECE370A-C805-4EFA-A77B-4C51A96E778C @default.
- Q64109963 P2888 Q64109963-37A74232-568C-4B10-A8A7-A1359EDE9B3E @default.
- Q64109963 P304 Q64109963-FEBFD300-AEC8-4EC8-A40F-D3A406012999 @default.
- Q64109963 P31 Q64109963-6A098B4A-B1F5-47EE-959A-D724E23ACE14 @default.
- Q64109963 P356 Q64109963-92713D6B-2206-4D47-B77C-DA74AFE0E25A @default.
- Q64109963 P407 Q64109963-EA4F05B6-0150-401B-A47A-71EAFA46A83C @default.
- Q64109963 P433 Q64109963-9239DA05-17A2-482D-A767-28A47FD3C790 @default.
- Q64109963 P478 Q64109963-9FB79BE9-D195-4366-AB09-612B15203BE6 @default.
- Q64109963 P577 Q64109963-1812AAA7-7C5E-4F87-B2B9-0E78F32DABD0 @default.
- Q64109963 P6179 Q64109963-AC2938C7-F5E7-4A95-A650-8EE0D0DC60F7 @default.
- Q64109963 P698 Q64109963-CBDEC8D7-AE64-4EFB-AC77-4984554BD064 @default.
- Q64109963 P356 LEU.2015.220 @default.
- Q64109963 P698 26369829 @default.
- Q64109963 P1433 Q6534498 @default.
- Q64109963 P1476 "Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry" @default.
- Q64109963 P2093 "A A van de Loosdrecht" @default.
- Q64109963 P2093 "A G Dinmohamed" @default.
- Q64109963 P2093 "E F M Posthuma" @default.
- Q64109963 P2093 "M Jongen-Lavrencic" @default.
- Q64109963 P2093 "O Visser" @default.
- Q64109963 P2093 "P C Huijgens" @default.
- Q64109963 P2093 "P Sonneveld" @default.
- Q64109963 P2093 "Y van Norden" @default.
- Q64109963 P2860 Q24563021 @default.
- Q64109963 P2860 Q35859212 @default.
- Q64109963 P2860 Q37723835 @default.
- Q64109963 P2860 Q38297873 @default.
- Q64109963 P2860 Q40974681 @default.
- Q64109963 P2860 Q41471081 @default.
- Q64109963 P2860 Q44322943 @default.
- Q64109963 P2860 Q61988458 @default.
- Q64109963 P2888 leu.2015.220 @default.
- Q64109963 P304 "2449-2451" @default.
- Q64109963 P31 Q13442814 @default.
- Q64109963 P356 "10.1038/LEU.2015.220" @default.
- Q64109963 P407 Q1860 @default.
- Q64109963 P433 "12" @default.
- Q64109963 P478 "29" @default.
- Q64109963 P577 "2015-09-15T00:00:00Z" @default.
- Q64109963 P6179 "1043586319" @default.
- Q64109963 P698 "26369829" @default.